Humana AB (publ) (STO:HUM)
Sweden · Delayed Price · Currency is SEK 61.90
+0.70 (1.14%)
Jul 24, 2026, 5:29 PM CET
Humana AB Market Cap
Humana AB has a market cap or net worth of 2.94 billion as of July 24, 2026. Its market cap has increased by 66.25% in one year.
Market Cap
2.94B
Enterprise Value
7.09B
Revenue
10.04B
Ranking
n/a
PE Ratio
17.15
Stock Price
61.90
ChartMarket Cap Chart
Since March 22, 2016, Humana AB's market cap has decreased from 3.40B to 2.94B, a decrease of -13.36%. That is a compound annual growth rate of -1.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 2.94B | 18.59% |
| Dec 30, 2025 | 2.48B | 34.25% |
| Dec 30, 2024 | 1.85B | 37.23% |
| Dec 29, 2023 | 1.35B | -26.88% |
| Dec 30, 2022 | 1.84B | -48.20% |
| Dec 30, 2021 | 3.55B | 18.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 158.85B |
| Getinge AB | 62.73B |
| Sectra AB | 51.21B |
| Camurus AB | 36.66B |
| Hansa Biopharma AB | 4.01B |
| CellaVision AB | 3.34B |
| Vicore Pharma Holding AB | 3.16B |
| Egetis Therapeutics AB | 3.12B |